Aim: Pancreaticobiliary maljunction (PBM) with or without congenital biliary dilatation (CBD) is a risk factor for biliary tract cancer. We investigated long-term outcomes after biliary diversion operation with special reference to types of CBD. Results: Of 40 patients, nine patients suffered from repeated cholangitis and eight of these nine patients suffered from hepatolithiasis after biliary diversion operation.
| INTRODUC TI ON
Pancreaticobiliary maljunction (PBM) is a congenital malformation in which the pancreatic and bile ducts merge anatomically outside the duodenal wall, causing bile and pancreatic juice to flow into each other because the sphincter of Oddi cannot control the junction. In most patients, PBM is associated with congenital biliary dilatation (CBD). It is well known that PBM with or without CBD is a risk factor for biliary tract cancer. [1] [2] [3] [4] [5] [6] The reflux of pancreatic juice into the biliary tract caused by PBM is thought to play a significant role in the development of biliary tract cancers, such as gallbladder cancer and cholangiocarcinoma in dilated bile ducts. 6 Therefore, excision of the extrahepatic bile duct and cholecystectomy with hepaticojejunostomy using Roux-en-Y (the socalled biliary diversion operation) is recommended to reduce the risk of biliary tract cancer. 5 Late postoperative complications after the biliary diversion operation are known to include cholangitis and hepatolithiasis. In addition, it has been reported that biliary tract cancer can develop after the biliary diversion operation.
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Previous studies have reported that the rates of these complications seem to be higher in patients with type IV-A CBD compared to those with other types of CBD. 6, 9, 11, 12 However, previous studies did not compare long-term outcomes after the biliary diversion operation between patients with type IV-A CBD and those with other types of CBD. In this study, we investigated the long-term outcomes including biliary tract cancer, after the biliary diversion operation in adult patients, with a special reference to the types of CBD.
| PATIENTS AND ME THODS

| Patients
The subjects in this study were 40 adult patients (eight men, 32
women) who underwent excision of the biliary diversion operation for PBM without biliary tract cancer (Table 1) . For the purpose of this study, the biliary diversion operation was defined as excision of the total (dilated or non-dilated) extrahepatic bile duct and cholecystectomy with hepaticojejunostomy using Roux-en-Y to prevent reflux of pancreatic juice into the biliary tract and reflux of bile into the pancreatic duct. PBM was diagnosed according to the diagnostic criteria for PBM by the Japanese Study Group on PBM. 13 CBD was diagnosed according to the diagnostic criteria for CBD 14 and the type of CBD was classified according to Todani's classification. 7 Patient ages ranged from 20 to 73 years (median 45). Of the 40 patients, 38 had CBD and two had non-dilated extrahepatic bile ducts. Of the 38 patients with CBD, the type of CBD was classified as type Ia in nine patients, type Ic in nine patients, and type IV-A in 20 patients.
Of the 40 patients, five had previously undergone choledochoduodenostomy (cyst-duodenostomy), one had previously undergone choledocho-jejunostomy (cyst-jejunostomy), one had previously undergone cholecystectomy, and one had previously undergone posterior segmentectomy for hepatolithiasis. At the biliary diversion operation, seven patients had hepatolithiasis, and four of these seven had undergone choledocho-duodenostomy or choledocho-jejunostomy. Of the 40 patients, liver resection was also performed at the time of the biliary diversion operation in five patients.
One patient had a history of distal gastrectomy for gastric cancer. One patient was associated with intraluminal duodenal diverticulum 15 and another patient was associated with annular pancreas.
| Follow-up
After the biliary diversion operation, patients were followed up at 
| Statistics
Continuous variables were compared between groups using Student's t test or Mann-Whitney U test. Categorical data were compared using Fisher's exact test. We used the Kaplan-Meier method to calculate the overall survival rates and differences between the two groups, which were evaluated using the log-rank test. A P value of <.05 was considered statistically significant. All statistical analyses were performed using SPSS ® v.22.0 software (IBM Corp., Armonk, NY, USA).
| RE SULTS
| Outcomes after the biliary diversion operation in all patients
Of the 40 patients, repeated cholangitis occurred in nine patients and hepatolithiasis developed in eight of these nine patients after the biliary diversion operation. During the follow-up periods, biliary tract cancer developed in three patients and pancreatic cancer developed in one patient (Table 2 ). In one pa- 
| Comparison of postoperative outcomes between groups
The proportions of patients with repeated cholangitis and hepatolithiasis were significantly higher in group B (type IV-A) than in group A (other types; P = .0197 and P = .0436, respectively; Table 3 ). Although no patients in group A died during the followup period, four patients in group B died of cholangiocarcinoma, pancreatic cancer, or hepatic failure. The proportion of deceased patients was significantly higher in group B than in group A (P = .0471). The proportion of patients who required re-operation was significantly higher in group B than in group A (P = .0471). Figure 2 shows the survival curves after the operation in the two groups. The survival rate was significantly worse in group B than in group A (P = .039).
| D ISCUSS I ON
Of the 40 patients in this study, nine suffered from repeated cholangitis and eight of these nine suffered from hepatolithiasis after the biliary diversion operation. Biliary tract cancer developed in three patients and pancreatic cancer developed in one patient after the operation. One patient died of hepatic failure caused by repeated cholangitis and hepatolithiasis. The rate of cholangiocarcinoma or hepatolithiasis after the biliary diversion operation was significantly higher in patients with postoperative repeated cholangitis than in patients without such cholangitis, especially in group B. As the result, the proportions of patients with repeated cholangitis or hepatolithiasis, patients who died of biliary tract cancer, pancreatic cancer, or hepatic failure, and patients who underwent re-operation under laparotomy were significantly higher in group B (type IV-A) than in group A (other types). The survival rate was significantly lower in group B than in group A.
In a Japanese nationwide survey, biliary tract cancer was observed in 215 (21.6%) of 997 adult patients with PBM and CHD and in 218 (42.4%) of 514 adult patients with PBM without biliary dilatation. 4 Regarding the development of biliary tract cancer after the biliary diversion operation for PBM with or without CBD, Watanabe et al. 8 reported that the incidence was 0.7% (nine out of 1291 patients) in a review of the Japanese literature. Kobayashi et al. 9 reported that biliary tract cancer developed after the biliary diversion operation in three (5.4%) of 56 patients. Ohashi et al.
10
reported that cancer developed in four (4.3%) of 94 patients and that the sites of biliary tract cancer were intrahepatic (n = 2), hilar (n = 1), and intrapancreatic (n = 1). Ohashi et al. also reported that the cumulative incidence was 11.3% at 25 years. In this study, biliary tract cancer developed in three (7.5%) out of 40 patients after the biliary diversion operation, namely intrahepatic (n = 1), hilar (n = 1)
and intrapancreatic (n = 1). Therefore, biliary tract cancer developed in approximately 10% of patients who underwent the biliary diversion operation. Watanabe et al. 8 reported that the interval between cyst excision (the biliary diversion operation) and the detection of the cancer after the biliary diversion operation was 1-19 years (average, 9.0 ± 5.5 years). Kobayashi et al. 9 reported that cancer developed at 19 years and 6 months, 8 years and 8 months, and 2 years and 5 months after the biliary diversion operation. Ohashi et al.
reported that cancer developed at 13, 15, 23, and 32 years after the operation. In this study, biliary tract cancer was detected at 3 years and 2 months, 4 years and 1 month, and 24 years after the biliary diversion operation. Therefore, it is necessary to pay attention to cancer development for the long-term even after the biliary diversion operation.
Kobayashi et al. 9 reported that CBD in all three patients with biliary tract cancer after the biliary diversion operation was classified as type IV-A. Ohashi et al. 10 reported four patients with such biliary tract cancer, two of whom had type IV-A CBD. In this study, all three patients with biliary tract cancer after the biliary diversion operation had type IV-A CBD. Notably, the proportion of patients with repeated cholangitis with or without hepatolithiasis was significantly higher in group B (type IV-A) than in group A. Furthermore, the rate of cholangiocarcinoma or hepatolithiasis after the biliary di- In this study, cholangiocarcinoma developed in the intrapancreatic bile duct in one patient. Therefore, the intrapancreatic bile duct should be dissected at the level immediately above the pancreaticobiliary junction, so as to leave as little intrapancreatic bile duct as possible. To resect the intrapancreatic bile duct as much as possible, intraoperative cholangiography using a metal clip or biliary endoscopy is reported to be useful.
In one patient in our study, pancreatic cancer developed 5 years and 8 months after the biliary diversion operation. Morine et al. 4 reported pancreatic cancer in 14 of 1511 (0.93%) adult patients with PBM which is higher than the incidence rate of pancreatic cancer (around 30 per 100 000) in Japan. 22 Patients who develop pancreatic cancer after CBD surgery have been reported. 23 In the present study, fluctuation in serum amylase activity was observed in one patient who developed pancreatic cancer after the operation. Minami Previous studies have suggested that the proportion of patients with late complications such as cholangitis, hepatolithiasis, and biliary tract cancer after the biliary tract operation seems to be higher in patients with type IV-A CBD than in those with other types of CBD, 6, 9, 11, 12 and this study clearly showed that the longterm outcomes were more unfavorable in patients with type IV-A CBD compared to those with other types of CBD in terms of late postoperative complications and survival rate. Therefore, in patients with type IV-A CBD, an exact diagnosis of the dilatation and stenosis of the bile ducts and appropriate treatment is essential to improve outcomes after the biliary diversion operation. Careful long-term follow-up with measurement of serum tumor markers such as CA 19-9 is important after the biliary diversion operation for PBM, especially in patients with IV-A CBD or repeated cholangitis.
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